Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$656M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$612M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$353M |
| 5 |
Walmart
WMT
|
+$316M |
Top Sells
| 1 |
Apple
AAPL
|
+$483M |
| 2 |
PepsiCo
PEP
|
+$394M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$248M |
| 4 |
Philip Morris
PM
|
+$246M |
| 5 |
Eli Lilly
LLY
|
+$240M |
Sector Composition
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Sangamo Therapeutics
SGMO
$155M
| $606K | ﹤0.01% |
67,000
-559,800
| -89% | -$5.06M |
|
2802
BioCryst Pharmaceuticals
BCRX
$1.62B
| $604K | ﹤0.01% |
+210,815
| New | +$604K |
|
|
NEOS
2803
DELISTED
Neos Therapeutics, Inc
NEOS
| $604K | ﹤0.01% |
408,162
+266,607
| +188% | +$395K |
|
|
SECO
2804
DELISTED
Secoo Holding Limited ADR
SECO
| $602K | ﹤0.01% |
8,990
-3,000
| -25% | -$201K |
|
2805
AXT Inc
AXTI
$182M
| $598K | ﹤0.01% |
168,000
-14,467
| -8% | -$51.5K |
|
|
RRTS
2806
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $597K | ﹤0.01% |
57,588
+12,500
| +28% | +$130K |
|
2807
Mannatech
MTEX
$18.1M
| $595K | ﹤0.01% |
34,017
+4,620
| +16% | +$80.8K |
|
2808
Check-Cap
CHEK
$13.6M
| $593K | ﹤0.01% |
15,778
+405
| +3% | +$15.2K |
|
|
GNCA
2809
DELISTED
Genocea Biosciences, Inc.
GNCA
| $590K | ﹤0.01% |
203,362
+36,975
| +22% | +$107K |
|
2810
ProQR Therapeutics
PRQR
$217M
| $589K | ﹤0.01% |
102,300
+84,500
| +475% | +$487K |
|
2811
Vanguard FTSE All-World ex-US ETF
VEU
$50.6B
| $589K | ﹤0.01% |
11,800
-28,000
| -70% | -$1.4M |
|
|
MDP
2812
DELISTED
Meredith Corporation
MDP
| $587K | ﹤0.01% |
+16,000
| New | +$587K |
|
|
GLIBA
2813
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $584K | ﹤0.01% |
+9,410
| New | +$584K |
|
|
FLXN
2814
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $581K | ﹤0.01% |
+42,400
| New | +$581K |
|
|
GSUM
2815
DELISTED
Gridsum Holding Inc.
GSUM
| $581K | ﹤0.01% |
346,026
-761
| -0.2% | -$1.28K |
|
|
CRESY
2816
Cresud
CRESY
$555M
| $580K | ﹤0.01% |
103,944
+71,839
| +224% | +$401K |
|
2817
Boston Omaha
BOC
$420M
| $579K | ﹤0.01% |
29,200
+17,500
| +150% | +$347K |
|
2818
Stagwell
STGW
$1.35B
| $576K | ﹤0.01% |
204,400
-28,000
| -12% | -$78.9K |
|
|
TCON
2819
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $576K | ﹤0.01% |
6,439
+393
| +7% | +$35.2K |
|
2820
Gannett
GCI
$626M
| $576K | ﹤0.01% |
+65,404
| New | +$576K |
|
2821
Waste Management
WM
$86.9B
| $575K | ﹤0.01% |
+5,000
| New | +$575K |
|
2822
Twin Disc
TWIN
$191M
| $574K | ﹤0.01% |
54,193
+7,000
| +15% | +$74.1K |
|
|
SMIT
2823
DELISTED
Schmitt Industries Inc
SMIT
| $572K | ﹤0.01% |
261,048
+700
| +0.3% | +$1.53K |
|
2824
First Trust Natural Gas ETF
FCG
$336M
| $571K | ﹤0.01% |
+49,800
| New | +$571K |
|
2825
OneSpan
OSPN
$605M
| $571K | ﹤0.01% |
39,370
-70,299
| -64% | -$1.02M |
|